Using a fingerstick test for haematological monitoring in patients treated with clozapine

BACKGROUND: Treatment with clozapine requires regular blood monitoring in order to minimise the risk of agranulocytosis. The demands on patients and clinicians associated with monitoring may be reduced by using point-of-care, as opposed to lab-based assessments. We assessed the utility of a device t...

Descripción completa

Detalles Bibliográficos
Autores principales: Atkins, Matthew, McGuire, Philip, Balgobin, Bhirundra, Patel, Pravinkumar, Taylor, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010800/
https://www.ncbi.nlm.nih.gov/pubmed/33854764
http://dx.doi.org/10.1177/20451253211000865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010800/
https://www.ncbi.nlm.nih.gov/pubmed/33854764
http://dx.doi.org/10.1177/20451253211000865

Ejemplares similares